 Xun Ai
Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitogen-Activated Protein Kinase 9 | 6 | 2021 | 16 | 4.520 |
Why?
| | Connexin 43 | 12 | 2021 | 21 | 3.700 |
Why?
| | Myocytes, Cardiac | 16 | 2022 | 217 | 3.330 |
Why?
| | Atrial Fibrillation | 9 | 2022 | 197 | 3.240 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 9 | 2021 | 43 | 3.130 |
Why?
| | Arrhythmias, Cardiac | 10 | 2022 | 158 | 2.800 |
Why?
| | Gap Junctions | 8 | 2021 | 23 | 2.680 |
Why?
| | Calcium Signaling | 5 | 2022 | 188 | 2.330 |
Why?
| | Heart Failure | 12 | 2021 | 232 | 2.260 |
Why?
| | Heart Atria | 8 | 2021 | 89 | 2.000 |
Why?
| | Rabbits | 15 | 2021 | 326 | 1.530 |
Why?
| | Binge Drinking | 2 | 2020 | 13 | 1.530 |
Why?
| | Animals | 32 | 2022 | 5312 | 1.470 |
Why?
| | Sarcoplasmic Reticulum | 7 | 2022 | 233 | 1.390 |
Why?
| | Atrial Remodeling | 3 | 2021 | 9 | 1.240 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2017 | 19 | 1.160 |
Why?
| | Heart | 3 | 2021 | 110 | 0.990 |
Why?
| | Heart Diseases | 2 | 2022 | 102 | 0.960 |
Why?
| | Aging | 5 | 2021 | 1614 | 0.940 |
Why?
| | Phosphorylation | 12 | 2021 | 199 | 0.920 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2020 | 37 | 0.900 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 5 | 2022 | 176 | 0.900 |
Why?
| | Cells, Cultured | 9 | 2020 | 802 | 0.890 |
Why?
| | Myocardium | 3 | 2019 | 183 | 0.880 |
Why?
| | Genes, Essential | 1 | 2021 | 2 | 0.860 |
Why?
| | Immunoblotting | 1 | 2021 | 65 | 0.850 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2020 | 39 | 0.830 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 548 | 0.810 |
Why?
| | Behavior, Animal | 1 | 2020 | 113 | 0.780 |
Why?
| | Sleep Apnea Syndromes | 1 | 2020 | 36 | 0.780 |
Why?
| | DNA Methylation | 1 | 2020 | 168 | 0.730 |
Why?
| | Heart Ventricles | 8 | 2021 | 218 | 0.720 |
Why?
| | Ion Channels | 1 | 2021 | 232 | 0.720 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 351 | 0.710 |
Why?
| | Calcium | 7 | 2022 | 519 | 0.690 |
Why?
| | Phosphoprotein Phosphatases | 3 | 2021 | 8 | 0.670 |
Why?
| | Heart Conduction System | 4 | 2021 | 29 | 0.620 |
Why?
| | Ethanol | 1 | 2018 | 138 | 0.610 |
Why?
| | Humans | 25 | 2022 | 31481 | 0.590 |
Why?
| | Calcium Channels | 2 | 2015 | 137 | 0.590 |
Why?
| | MAP Kinase Signaling System | 1 | 2016 | 46 | 0.580 |
Why?
| | Epicardial Mapping | 1 | 2015 | 4 | 0.570 |
Why?
| | Action Potentials | 5 | 2021 | 143 | 0.530 |
Why?
| | Collagen | 1 | 2014 | 111 | 0.530 |
Why?
| | Male | 21 | 2021 | 17583 | 0.510 |
Why?
| | Enzyme Activation | 3 | 2018 | 140 | 0.500 |
Why?
| | Mice | 8 | 2020 | 1894 | 0.500 |
Why?
| | Ventricular Function, Left | 4 | 2021 | 63 | 0.470 |
Why?
| | Cell Line | 3 | 2018 | 360 | 0.460 |
Why?
| | p21-Activated Kinases | 1 | 2011 | 13 | 0.430 |
Why?
| | Mice, Transgenic | 5 | 2019 | 308 | 0.410 |
Why?
| | Cell Communication | 3 | 2021 | 36 | 0.380 |
Why?
| | Heart Rate | 2 | 2020 | 161 | 0.380 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 108 | 0.370 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 2018 | 12 | 0.350 |
Why?
| | HEK293 Cells | 2 | 2020 | 89 | 0.310 |
Why?
| | Middle Aged | 8 | 2021 | 11209 | 0.300 |
Why?
| | Female | 15 | 2021 | 18253 | 0.300 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2005 | 28 | 0.290 |
Why?
| | Tachycardia, Ventricular | 2 | 2021 | 35 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 1 | 2004 | 45 | 0.280 |
Why?
| | Cadherins | 3 | 2014 | 38 | 0.270 |
Why?
| | Aged | 5 | 2021 | 10295 | 0.260 |
Why?
| | Down-Regulation | 2 | 2017 | 134 | 0.250 |
Why?
| | Serine | 2 | 2021 | 15 | 0.250 |
Why?
| | Disease Models, Animal | 6 | 2021 | 832 | 0.240 |
Why?
| | Fibroblasts | 2 | 2021 | 98 | 0.220 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 71 | 0.220 |
Why?
| | Mice, Knockout | 2 | 2020 | 399 | 0.220 |
Why?
| | Threonine | 1 | 2021 | 15 | 0.220 |
Why?
| | Binding Sites | 2 | 2018 | 93 | 0.220 |
Why?
| | RNA, Messenger | 2 | 2017 | 371 | 0.220 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2021 | 2 | 0.220 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 1 | 0.220 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 111 | 0.220 |
Why?
| | Ventricular Fibrillation | 1 | 2021 | 27 | 0.210 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 34 | 0.210 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2021 | 54 | 0.210 |
Why?
| | Actins | 1 | 2021 | 63 | 0.210 |
Why?
| | Calsequestrin | 1 | 2021 | 39 | 0.210 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2020 | 3 | 0.210 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2020 | 18 | 0.200 |
Why?
| | Atrioventricular Node | 1 | 2020 | 3 | 0.200 |
Why?
| | Amygdala | 1 | 2020 | 56 | 0.200 |
Why?
| | Adult | 5 | 2018 | 9779 | 0.200 |
Why?
| | Sodium | 1 | 2020 | 81 | 0.190 |
Why?
| | Oxidative Stress | 1 | 2020 | 140 | 0.190 |
Why?
| | Connexins | 2 | 2020 | 5 | 0.190 |
Why?
| | Calpain | 1 | 2019 | 6 | 0.190 |
Why?
| | Anxiety | 1 | 2020 | 162 | 0.190 |
Why?
| | Cardiotonic Agents | 1 | 2019 | 20 | 0.190 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2019 | 22 | 0.190 |
Why?
| | Prefrontal Cortex | 1 | 2020 | 152 | 0.190 |
Why?
| | Topoisomerase I Inhibitors | 1 | 2018 | 1 | 0.180 |
Why?
| | Camptothecin | 1 | 2018 | 6 | 0.180 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 7 | 0.180 |
Why?
| | Carrier Proteins | 1 | 2019 | 129 | 0.180 |
Why?
| | Transcriptional Activation | 1 | 2018 | 30 | 0.170 |
Why?
| | TNF Receptor-Associated Factor 3 | 1 | 2017 | 1 | 0.170 |
Why?
| | Hippocampus | 1 | 2020 | 295 | 0.170 |
Why?
| | Platelet Aggregation | 1 | 2017 | 9 | 0.170 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 40 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2017 | 16 | 0.170 |
Why?
| | Transcription, Genetic | 1 | 2018 | 125 | 0.170 |
Why?
| | Echocardiography | 2 | 2011 | 197 | 0.170 |
Why?
| | Isoquinolines | 2 | 2009 | 16 | 0.170 |
Why?
| | Cell Proliferation | 1 | 2018 | 232 | 0.160 |
Why?
| | Thrombosis | 1 | 2017 | 67 | 0.160 |
Why?
| | Apoptosis | 1 | 2018 | 292 | 0.160 |
Why?
| | Obesity | 1 | 2020 | 338 | 0.160 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 125 | 0.150 |
Why?
| | Atrial Function | 1 | 2015 | 12 | 0.140 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 10 | 0.140 |
Why?
| | Age Factors | 1 | 2018 | 943 | 0.140 |
Why?
| | Extracellular Fluid | 1 | 2014 | 4 | 0.140 |
Why?
| | Gene Deletion | 1 | 2014 | 57 | 0.140 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 128 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2014 | 31 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 227 | 0.120 |
Why?
| | Anisomycin | 1 | 2012 | 1 | 0.120 |
Why?
| | Delayed Rectifier Potassium Channels | 1 | 2012 | 4 | 0.120 |
Why?
| | Anthracenes | 1 | 2012 | 6 | 0.120 |
Why?
| | Sympathetic Nervous System | 1 | 2012 | 14 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2014 | 494 | 0.120 |
Why?
| | Gonadal Steroid Hormones | 1 | 2012 | 13 | 0.120 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2012 | 14 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2012 | 248 | 0.120 |
Why?
| | Cordyceps | 1 | 2012 | 1 | 0.120 |
Why?
| | Selenium | 1 | 2012 | 10 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 160 | 0.110 |
Why?
| | Cognition | 1 | 2020 | 1206 | 0.110 |
Why?
| | Protein Phosphatase 2 | 1 | 2011 | 1 | 0.110 |
Why?
| | Up-Regulation | 3 | 2021 | 220 | 0.110 |
Why?
| | Fibrosis | 2 | 2021 | 53 | 0.100 |
Why?
| | Signal Transduction | 3 | 2020 | 588 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2012 | 13 | 0.100 |
Why?
| | Death, Sudden, Cardiac | 1 | 2009 | 30 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 72 | 0.100 |
Why?
| | Fluorescent Dyes | 1 | 2009 | 71 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 15 | 0.090 |
Why?
| | Rats | 3 | 2022 | 966 | 0.090 |
Why?
| | Biological Clocks | 1 | 2008 | 17 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2008 | 8 | 0.090 |
Why?
| | Tissue Engineering | 1 | 2008 | 50 | 0.090 |
Why?
| | Pacemaker, Artificial | 1 | 2008 | 32 | 0.090 |
Why?
| | Young Adult | 1 | 2014 | 2277 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2014 | 5234 | 0.080 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2005 | 2 | 0.070 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2005 | 4 | 0.070 |
Why?
| | Benzylamines | 1 | 2005 | 15 | 0.070 |
Why?
| | Calcium-Transporting ATPases | 1 | 2005 | 26 | 0.070 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2005 | 41 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 40 | 0.070 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2005 | 8 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2005 | 34 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2005 | 36 | 0.070 |
Why?
| | Sulfonamides | 1 | 2005 | 64 | 0.070 |
Why?
| | Coloring Agents | 1 | 2004 | 16 | 0.070 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 11 | 0.070 |
Why?
| | Nerve Regeneration | 1 | 2004 | 17 | 0.070 |
Why?
| | Sciatic Nerve | 1 | 2004 | 32 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2005 | 230 | 0.060 |
Why?
| | Oxidoreductases | 1 | 2022 | 12 | 0.060 |
Why?
| | Isoproterenol | 1 | 2022 | 19 | 0.060 |
Why?
| | Electric Conductivity | 1 | 2021 | 85 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 133 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 2 | 2012 | 20 | 0.050 |
Why?
| | Dogs | 1 | 2021 | 283 | 0.050 |
Why?
| | Kv1.5 Potassium Channel | 1 | 2020 | 2 | 0.050 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2012 | 45 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2020 | 27 | 0.050 |
Why?
| | Mitochondria, Heart | 1 | 2020 | 21 | 0.050 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 14 | 0.050 |
Why?
| | Myosin Heavy Chains | 1 | 2020 | 11 | 0.050 |
Why?
| | Calcium Channels, L-Type | 1 | 2020 | 62 | 0.050 |
Why?
| | Antioxidants | 1 | 2020 | 70 | 0.050 |
Why?
| | Heart Function Tests | 1 | 2019 | 5 | 0.050 |
Why?
| | Proteolysis | 1 | 2019 | 20 | 0.050 |
Why?
| | Telemetry | 1 | 2019 | 15 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 3 | 0.050 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2018 | 2 | 0.050 |
Why?
| | HT29 Cells | 1 | 2018 | 10 | 0.050 |
Why?
| | HCT116 Cells | 1 | 2018 | 12 | 0.050 |
Why?
| | Swine | 1 | 2019 | 117 | 0.050 |
Why?
| | Molecular Structure | 1 | 2018 | 32 | 0.050 |
Why?
| | Mice, Nude | 1 | 2018 | 39 | 0.050 |
Why?
| | Computer-Aided Design | 1 | 2018 | 15 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 54 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 31 | 0.040 |
Why?
| | Drug Design | 1 | 2018 | 34 | 0.040 |
Why?
| | Protein Binding | 1 | 2018 | 155 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 296 | 0.040 |
Why?
| | Blood Platelets | 1 | 2017 | 52 | 0.040 |
Why?
| | Electrocardiography | 1 | 2019 | 209 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2019 | 187 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2014 | 77 | 0.030 |
Why?
| | Antigens, CD | 1 | 2014 | 106 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2014 | 87 | 0.030 |
Why?
| | Potassium Channel Blockers | 1 | 2012 | 7 | 0.030 |
Why?
| | Orchiectomy | 1 | 2012 | 7 | 0.030 |
Why?
| | Ovariectomy | 1 | 2012 | 29 | 0.030 |
Why?
| | Potassium | 1 | 2012 | 71 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 10 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 2012 | 4 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2012 | 10 | 0.030 |
Why?
| | Cardiomegaly | 1 | 2012 | 20 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2014 | 687 | 0.030 |
Why?
| | Fruiting Bodies, Fungal | 1 | 2012 | 1 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2012 | 22 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2012 | 79 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 67 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 63 | 0.030 |
Why?
| | Sex Factors | 1 | 2012 | 542 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 512 | 0.030 |
Why?
| | Mutation | 1 | 2012 | 464 | 0.020 |
Why?
| | Biomedical Engineering | 1 | 2008 | 6 | 0.020 |
Why?
| | Disease Progression | 1 | 2012 | 861 | 0.020 |
Why?
| | Ethanolamines | 1 | 2008 | 5 | 0.020 |
Why?
| | Electrophysiology | 1 | 2008 | 140 | 0.020 |
Why?
| | Propanolamines | 1 | 2008 | 11 | 0.020 |
Why?
| | Kinetics | 1 | 2008 | 278 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2008 | 125 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2008 | 174 | 0.020 |
Why?
| | Muscle Cells | 1 | 2007 | 15 | 0.020 |
Why?
| | Time Factors | 1 | 2012 | 1902 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 1273 | 0.020 |
Why?
| | Protein Subunits | 1 | 2005 | 24 | 0.020 |
Why?
| | Isoenzymes | 1 | 2005 | 63 | 0.020 |
Why?
| | Schwann Cells | 1 | 2004 | 3 | 0.020 |
Why?
| | Capillaries | 1 | 2004 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2004 | 30 | 0.020 |
Why?
| | Silicones | 1 | 2004 | 14 | 0.020 |
Why?
| | Nerve Fibers | 1 | 2004 | 17 | 0.020 |
Why?
| | Erythrocytes | 1 | 2004 | 31 | 0.020 |
Why?
| | Myelin Sheath | 1 | 2004 | 23 | 0.020 |
Why?
| | Monocytes | 1 | 2004 | 108 | 0.020 |
Why?
| | Macrophages | 1 | 2004 | 129 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2004 | 494 | 0.020 |
Why?
|
|
Ai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|